-
Je něco špatně v tomto záznamu ?
Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis
AS. Siebuhr, M. Hušaková, S. Forejtová, K. Zegzulková, M. Tomčik, M. Urbanová, K. Grobelná, J. Gatterová, AC. Bay-Jensen, K. Pavelka,
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1999 do Před 5 lety
Freely Accessible Science Journals
od 1999 do Před 4 lety
PubMed
30767876
Knihovny.cz E-zdroje
- MeSH
- ankylózující spondylitida metabolismus patologie MeSH
- C-reaktivní protein metabolismus MeSH
- kvalita života MeSH
- lidé MeSH
- spondylartritida metabolismus patologie MeSH
- vimentin metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: Non-radiographic (nr-axSpA) and radiographic (AS) forms of axial spondyloarthritis (axSpA) share clinical features, but have different radiographic patterns. Radiographic progression is not associated with the current disease activity biomarkers. We investigated a matrix metalloproteinase mediated metabolite of C-reactive protein (CRPM) and two biomarkers of citrullinated vimentin (VICM and anti-MCV) as novel biomarkers of disease activity. METHODS: AxSpA patients (n=121 nr-axSpA and n=72 AS) were characterised by activity (AS disease activity score with CRP [ASDAS-CRP], Bath AS disease activity index [BASDAI] and functional index [BASFI]), radiographic scores and quality of life questionnaires. CRPM, VICM and anti-MCV levels were analysed by ELISA in serum. Asymptomatic controls (n=100) were used as reference. Multiple regression investigated association with disease activity and diagnostic potential. RESULTS: CRPM and VICM levels were increased in AS compared to nr-axSpA (11.9nM vs. 10.2nM, p<0.001 and 4.92nM vs. 3.77nM, p=0.0025). Anti-MCV was similar in both axSpA subgroups, but lowered in controls. In nr-axSpA, CRPM correlated with CRP (ρ=0.33, p<0.001) and VICM (ρ=0.29, p=0.001); in AS, VICM correlated with CRP (ρ=0.34, p=0.0032) and ESR (ρ=0.38, p<0.001). ASDAS-CRP correlated with CRPM and anti-MCV, but when adjusting for CRP the correlation only remained with CRPM. CRPM and VICM separated the subgroups with odds ratios of 1.19 and 1.10 adjusted for age, gender, BMI, and disease duration. VICM lost significance when adjusting for CRP. CONCLUSIONS: CRPM was associated with disease activity in axSpA, and CRPM and VICM separated the axSpA groups. This study indicates that serological biomarkers may be novel biomarkers in axSpA.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027813
- 003
- CZ-PrNML
- 005
- 20211118143412.0
- 007
- ta
- 008
- 190813s2019 it f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)30767876
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Siebuhr, Anne Sofie $u Nordic Bioscience Biomarkers and Research, Herlev, Denmark. aso@nordicbio.com.
- 245 10
- $a Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis / $c AS. Siebuhr, M. Hušaková, S. Forejtová, K. Zegzulková, M. Tomčik, M. Urbanová, K. Grobelná, J. Gatterová, AC. Bay-Jensen, K. Pavelka,
- 520 9_
- $a OBJECTIVES: Non-radiographic (nr-axSpA) and radiographic (AS) forms of axial spondyloarthritis (axSpA) share clinical features, but have different radiographic patterns. Radiographic progression is not associated with the current disease activity biomarkers. We investigated a matrix metalloproteinase mediated metabolite of C-reactive protein (CRPM) and two biomarkers of citrullinated vimentin (VICM and anti-MCV) as novel biomarkers of disease activity. METHODS: AxSpA patients (n=121 nr-axSpA and n=72 AS) were characterised by activity (AS disease activity score with CRP [ASDAS-CRP], Bath AS disease activity index [BASDAI] and functional index [BASFI]), radiographic scores and quality of life questionnaires. CRPM, VICM and anti-MCV levels were analysed by ELISA in serum. Asymptomatic controls (n=100) were used as reference. Multiple regression investigated association with disease activity and diagnostic potential. RESULTS: CRPM and VICM levels were increased in AS compared to nr-axSpA (11.9nM vs. 10.2nM, p<0.001 and 4.92nM vs. 3.77nM, p=0.0025). Anti-MCV was similar in both axSpA subgroups, but lowered in controls. In nr-axSpA, CRPM correlated with CRP (ρ=0.33, p<0.001) and VICM (ρ=0.29, p=0.001); in AS, VICM correlated with CRP (ρ=0.34, p=0.0032) and ESR (ρ=0.38, p<0.001). ASDAS-CRP correlated with CRPM and anti-MCV, but when adjusting for CRP the correlation only remained with CRPM. CRPM and VICM separated the subgroups with odds ratios of 1.19 and 1.10 adjusted for age, gender, BMI, and disease duration. VICM lost significance when adjusting for CRP. CONCLUSIONS: CRPM was associated with disease activity in axSpA, and CRPM and VICM separated the axSpA groups. This study indicates that serological biomarkers may be novel biomarkers in axSpA.
- 650 _2
- $a C-reaktivní protein $x metabolismus $7 D002097
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a spondylartritida $x metabolismus $x patologie $7 D025241
- 650 _2
- $a ankylózující spondylitida $x metabolismus $x patologie $7 D013167
- 650 _2
- $a vimentin $x metabolismus $7 D014746
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hušaková, Markéta $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Forejtová, Sarka $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Mintálová, Kateřina $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. $7 xx0228082
- 700 1_
- $a Tomčik, Michal $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Urbanová, Monika $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. $7 xx0210376
- 700 1_
- $a Grobelná, Kristina $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Gatterová, Jindra $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Bay-Jensen, Anne-Christine $u Nordic Bioscience Biomarkers and Research, Herlev, Denmark.
- 700 1_
- $a Pavelka, Karel $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00001116 $t Clinical and experimental rheumatology $x 0392-856X $g Roč. 37, č. 3 (2019), s. 358-366
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30767876 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20211118143414 $b ABA008
- 999 __
- $a ok $b bmc $g 1432962 $s 1066273
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 37 $c 3 $d 358-366 $e 20190211 $i 0392-856X $m Clinical and Experimental Rheumatology $n Clin Exp Rheumatol $x MED00001116
- LZP __
- $a Pubmed-20190813